Inspire Medical Systems Operating Margin 2017-2023 | INSP
Current and historical operating margin for Inspire Medical Systems (INSP) over the last 10 years. The current operating profit margin for Inspire Medical Systems as of December 31, 2023 is -3.39%.
| Inspire Medical Systems Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2023-12-31 | $0.63B | $-0.04B | -6.40% |
| 2023-09-30 | $0.57B | $-0.05B | -8.60% |
| 2023-06-30 | $0.53B | $-0.05B | -10.08% |
| 2023-03-31 | $0.47B | $-0.05B | -10.73% |
| 2022-12-31 | $0.41B | $-0.05B | -11.55% |
| 2022-09-30 | $0.35B | $-0.05B | -14.12% |
| 2022-06-30 | $0.30B | $-0.04B | -14.00% |
| 2022-03-31 | $0.26B | $-0.04B | -15.65% |
| 2021-12-31 | $0.23B | $-0.04B | -17.60% |
| 2021-09-30 | $0.20B | $-0.05B | -22.89% |
| 2021-06-30 | $0.18B | $-0.05B | -26.29% |
| 2021-03-31 | $0.13B | $-0.06B | -41.79% |
| 2020-12-31 | $0.12B | $-0.06B | -48.70% |
| 2020-09-30 | $0.10B | $-0.06B | -60.42% |
| 2020-06-30 | $0.08B | $-0.06B | -70.37% |
| 2020-03-31 | $0.09B | $-0.04B | -48.28% |
| 2019-12-31 | $0.08B | $-0.04B | -42.68% |
| 2019-09-30 | $0.07B | $-0.03B | -43.06% |
| 2019-06-30 | $0.06B | $-0.03B | -42.19% |
| 2019-03-31 | $0.06B | $-0.03B | -43.86% |
| 2018-12-31 | $0.05B | $-0.02B | -41.18% |
| 2018-09-30 | $0.04B | $-0.02B | -45.45% |
| 2018-06-30 | $0.04B | $-0.02B | -50.00% |
| 2018-03-31 | $0.03B | $-0.02B | -51.52% |
| 2017-12-31 | $0.03B | $-0.02B | -57.14% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $7.194B | $0.625B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $39.354B | 21.89 |
| IRhythm Technologies (IRTC) | United States | $3.483B | 0.00 |
| Axonics (AXNX) | United States | $3.401B | 0.00 |
| 10x Genomics (TXG) | United States | $3.288B | 0.00 |
| Enovis (ENOV) | United States | $3.030B | 23.02 |
| Azenta (AZTA) | United States | $2.910B | 237.18 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.840B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.678B | 0.00 |
| Privia Health (PRVA) | United States | $2.167B | 96.11 |
| Schrodinger (SDGR) | United States | $1.733B | 0.00 |
| Omnicell (OMCL) | United States | $1.279B | 31.30 |
| Phreesia (PHR) | United States | $1.162B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.823B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.762B | 0.00 |
| Standard BioTools (LAB) | United States | $0.708B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
| Talkspace (TALK) | United States | $0.527B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.353B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.337B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.328B | 0.00 |
| Pulmonx (LUNG) | United States | $0.281B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.162B | 0.00 |
| American Well (AMWL) | United States | $0.153B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.141B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.141B | 0.00 |
| Augmedix (AUGX) | United States | $0.139B | 0.00 |
| Outset Medical (OM) | United States | $0.124B | 0.00 |
| TruBridge (TBRG) | United States | $0.118B | 5.03 |
| 111 (YI) | China | $0.086B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.082B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.073B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.048B | 0.00 |
| Movano (MOVE) | United States | $0.047B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.035B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Cue Health (HLTH) | United States | $0.022B | 0.00 |
| Akili (AKLI) | United States | $0.019B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.018B | 0.00 |
| CareCloud (CCLD) | United States | $0.017B | 0.00 |
| ETAO (ETAO) | United States | $0.015B | 0.00 |
| Centogene (CNTG) | Germany | $0.013B | 0.00 |
| Biotricity (BTCY) | United States | $0.012B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |